PMGC Holdings Inc. (ELAB) vs Cellyan Biotechnology Co., Ltd (HKPD)
A side-by-side comparison of PMGC Holdings Inc. and Cellyan Biotechnology Co., Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ELAB
PMGC Holdings Inc.
$3.15HealthcareDelayed quote: Oct 6, 2026, 10:03 AM EDT
HKPD
Cellyan Biotechnology Co., Ltd
$0.10HealthcareDelayed quote: Oct 6, 2026, 10:05 AM EDT
Total return — ELAB vs HKPD
growth of $100 · dividends reinvested · last 2yELAB -100.0% (-99.2%/yr)HKPD -96.3% (-80.8%/yr)HKPD compounded faster over this window
Log scale — wide-divergence pair
ELAB HKPD
ELAB vs HKPD: by the numbers
- •ELAB is the larger company ($1M vs $1M market cap).
- •Both run net losses; HKPD's is the smaller (-8.46% vs -522.97% net margin).
Metrics side by side
Valuation
| Metric | ELAB | HKPD |
|---|---|---|
| P/S ratio | 0.56 | N/A |
| P/B ratio | 0.09 | 0.12 |
Profitability
| Metric | ELAB | HKPD |
|---|---|---|
| Gross margin | 10.31% | 10.32% |
| Operating margin | -1250.11% | -7.41% |
| Net margin | -522.97% | -8.46% |
| ROE | -80.57% | -11.85% |
| ROIC | N/A | -9.45% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.